Ignite Creation Date:
2024-05-06 @ 8:15 PM
Last Modification Date:
2024-10-26 @ 3:23 PM
Study NCT ID:
NCT06310616
Status:
RECRUITING
Last Update Posted:
2024-06-13
First Post:
2024-03-01
Brief Title:
A Study to Investigate the Potential Drug-Drug Interaction Between VH4524184 and Oral Contraceptive Loestrin in Healthy Adult Female Participants
Sponsor:
ViiV Healthcare
Organization:
ViiV Healthcare
Study Overview
Official Title:
A Phase 1 Single-center Open-label Study to Evaluate the Pharmacokinetics of Oral Contraceptive Containing Norethindrone and Ethinyl Estradiol Loestrin When Co-administered With VH4524184 in Healthy Adult Female Participants
Status:
RECRUITING
Status Verified Date:
2024-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study aims to assess any impact of VH4524184 on the pharmacokinetic PK profile of an ethinyl estradiol EE and norethindrone acetate NEA containing oral contraceptive OC administered to healthy adult female participants
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
True
Is an FDA AA801 Violation?:
None